Claudio Umberto Köser (Claudio U Köser)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 32

Top Topics

Multidrug Resistant

Particulate Matter

Staphylococcus Aureus

Top Venues

Antimicrobial agents and chemotherapy

The European respiratory journal

Microbiology spectrum

Genome medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Claudio Umberto Köser, Paolo Miotto, Nabila Ismail, Richard M Anthony, Christian Utpatel, Matthias Merker, Stefan Niemann, Sabira Tahseen, Leen Rigouts, Camilla Rodrigues, Shaheed Vally Omar, Maha Reda Farhat, Uladzimir Antonenka, Harald Hoffmann, Daniela Maria Cirillo, Thomas Schön
A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex. The European respiratory journal 64 (1) (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum 12 (3) (2024)
Paolo Miotto, Daniela M Cirillo, Thomas Schön, Claudio Umberto Köser
The exceptions that prove the rule-a historical view of bedaquiline susceptibility. Genome medicine 16 (1) (2024)
Claudio Umberto Köser, Paolo Miotto, Nabila Ismail, Richard M Anthony, Christian Utpatel, Matthias Merker, Stefan Niemann, Sabira Tahseen, Leen Rigouts, Camilla Rodrigues, Shaheed Vally Omar, Maha Reda Farhat, Uladzimir Antonenka, Harald Hoffmann, Daniela Maria Cirillo, Thomas Schön
A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex. The European respiratory journal 64 (1) (2024)
Paolo Miotto, Daniela M Cirillo, Thomas Schön, Claudio Umberto Köser
The exceptions that prove the rule-a historical view of bedaquiline susceptibility. Genome medicine 16 (1) (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum (2024)
Paolo Miotto, Daniela M Cirillo, Thomas Schön, Claudio Umberto Köser
The exceptions that prove the rule-a historical view of bedaquiline susceptibility. Genome medicine 16 (1) (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum 12 (3) (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum 12 (3) (2024)
Claudio Umberto Köser, Florian P Maurer
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex. The European respiratory journal 61 (5) (2023)
Claudio Umberto Köser, Florian P Maurer
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex. The European respiratory journal 61 (5) (2023)
Elin Economou Lundeberg, Viktoria Andersson, Maria Wijkander, Ramona Groenheit, Mikael Mansjö, Jim Werngren, Teresa Cortes, Ivan Barilar, Stefan Niemann, Matthias Merker, Claudio Umberto Köser, Lina Davies Forsman
In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex. Microbiology spectrum (2023)
Claudio Umberto Köser, Florian P Maurer
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex. The European respiratory journal 61 (5) (2023)
Sushil Pandey, Catherine Vilchèze, Jim Werngren, Arnold Bainomugisa, Mikael Mansjö, Ramona Groenheit, Paolo Miotto, Daniela Maria Cirillo, Christopher Coulter, Alain R Baulard, Thomas Schön, William R Jacobs, Kamel Djaout, Claudio Umberto Köser
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis . Antimicrobial agents and chemotherapy (2023)
Claudio Umberto Köser, Florian P Maurer
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex. The European respiratory journal 61 (5) (2023)
Anna Bateson, Julio Ortiz Canseco, Timothy D McHugh, Adam A Witney, Silke Feuerriegel, Matthias Merker, Thomas A Kohl, Christian Utpatel, Stefan Niemann, Sönke Andres, Katharina Kranzer, Florian P Maurer, Arash Ghodousi, Emanuele Borroni, Daniela Maria Cirillo, Maria Wijkander, Juan C Toro, Ramona Groenheit, Jim Werngren, Diana Machado, Miguel Viveiros, Robin M Warren, Frederick Sirgel, Anzaan Dippenaar, Claudio Umberto Köser, Eugene Sun, Juliano Timm
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid. The Journal of antimicrobial chemotherapy 77 (6) (2022)
Sagal Mohamed, Claudio Umberto Köser, Max Salfinger, Wladimir Sougakoff, Scott K Heysell
Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics? The European respiratory journal 57 (3) (2021)
Roger Vargas, Luca Freschi, Andrea Spitaleri, Sabira Tahseen, Ivan Barilar, Stefan Niemann, Paolo Miotto, Daniela Maria Cirillo, Claudio Umberto Köser, Maha Reda Farhat
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex. Antimicrobial agents and chemotherapy 65 (11) (2021)
Claudio Umberto Köser, Sophia B Georghiou, Thomas Schön, Max Salfinger
On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex. Journal of clinical microbiology 59 (4) (2021)
Riccardo Alagna, Andrea Maurizio Cabibbe, Paolo Miotto, Francesca Saluzzo, Claudio Umberto Köser, Stefan Niemann, Sebastien Gagneux, Camilla Rodrigues, Paola Vittoria Maria Rancoita, Daniela Maria Cirillo
Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice? The European respiratory journal 58 (1) (2021)
Claudio Umberto Köser, Daniela Maria Cirillo, Paolo Miotto
How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide. Antimicrobial agents and chemotherapy 64 (9) (2020)
Chloé Loiseau, Daniela Brites, Irmgard Moser, Francesc Coll, Christine Pourcel, Suelee Robbe-Austerman, Vincent Escuyer, Kimberlee A Musser, Sharon J Peacock, Silke Feuerriegel, Thomas A Kohl, Stefan Niemann, Sebastien Gagneux, Claudio Umberto Köser
Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex. Antimicrobial agents and chemotherapy 63 (6) (2019)
Arash Ghodousi, Elisa Tagliani, Eranga Karunaratne, Stefan Niemann, Jennifer Perera, Claudio Umberto Köser, Daniela Maria Cirillo
Isoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance Mechanisms. Antimicrobial agents and chemotherapy 63 (7) (2019)
Ewan M Harrison, Xiaoliang Ba, Francesc Coll, Beth Blane, Olivier Restif, Henry Carvell, Claudio Umberto Köser, Dorota Jamrozy, Sandra Reuter, Andrew Lovering, Nicholas Gleadall, Katherine L Bellis, Anne-Catrin Uhlemann, Franklin D Lowy, Ruth C Massey, Inês R Grilo, Rita Sobral, Jesper Larsen, Anders Rhod Larsen, Carina Vingsbo Lundberg, Julian Parkhill, Gavin K Paterson, Matthew T G Holden, Sharon J Peacock, Mark A Holmes
Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus. Nature microbiology 4 (10) (2019)
Jan Heyckendorf, Sönke Andres, Claudio Umberto Köser, Ioana Diana Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J Peacock, Stefan Niemann, Christoph Lange, Matthias Merker
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 62 (2) (2018)
Claudio Umberto Köser, Jan Heyckendorf, Sönke Andres, Ioana Diana Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J Peacock, Stefan Niemann, Christoph Lange, Matthias Merker
Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis". Antimicrobial agents and chemotherapy 62 (8) (2018)
Adebisi Ajileye, Nataly Alvarez, Matthias Merker, Timothy M Walker, Suriya Akter, Kerstin Brown, Danesh Moradigaravand, Thomas Schön, Sönke Andres, Viola Schleusener, Shaheed V Omar, Francesc Coll, Hairong Huang, Roland Diel, Nazir Ismail, Julian Parkhill, Bouke C de Jong, Tim E A Peto, Derrick W Crook, Stefan Niemann, Jaime Robledo, E Grace Smith, Sharon J Peacock, Claudio Umberto Köser
Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays. Antimicrobial agents and chemotherapy 61 (4) (2017)
Yoshio Nakatani, Helen K Opel-Reading, Matthias Merker, Diana Machado, Sönke Andres, S Siva Kumar, Danesh Moradigaravand, Francesc Coll, João Perdigão, Isabel Portugal, Thomas Schön, Dina Nair, K R Uma Devi, Thomas A Kohl, Patrick Beckert, Taane Gregory Clark, Gugu Maphalala, Derrick Khumalo, Roland Diel, Kadri Klaos, Htin Lin Aung, Gregory M Cook, Julian Parkhill, Sharon J Peacock, Soumya Swaminathan, Miguel Viveiros, Stefan Niemann, Kurt L Krause, Claudio Umberto Köser
Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance. Antimicrobial agents and chemotherapy 61 (12) (2017)
Louis Grandjean, Robert H Gilman, Tomatada Iwamoto, Claudio Umberto Köser, Jorge Coronel, Mirko Zimic, Michelle S Toleman, Diepreye Ayabina, Michelle Kendall, Christophe Fraser, Simon R Harris, Julian Parkhill, Sharon J Peacock, David A J Moore, Caroline Colijn
Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru. PloS one 12 (12) (2017)
Danesh Moradigaravand, Louis Grandjean, Elena Martinez, Hao Li, Jun Zheng, Jorge Coronel, David Moore, M Estée Török, Vitali Sintchenko, Hairong Huang, Babak Javid, Julian Parkhill, Sharon J Peacock, Claudio Umberto Köser
dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains. Antimicrobial agents and chemotherapy 60 (6) (2016)
Xia Yu, Guirong Wang, Suting Chen, Guomei Wei, Yuanyuan Shang, Lingling Dong, Thomas Schön, Danesh Moradigaravand, Julian Parkhill, Sharon J Peacock, Claudio Umberto Köser, Hairong Huang
Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Antimicrobial agents and chemotherapy 60 (9) (2016)